<div>Fun<wbr />ctional High-Risk</div>

A detailed infographic representing the fun<wbr>ctional high-risk patient group in oncology, showcasing key statistics and treatment response graphs, in a professional and educational style.

Functional High-Risk Quiz

Test your knowledge on the functional high-risk group in therapy! This quiz will assess your understanding of early relapse subgroups, treatment efficacy, and patient outcomes based on recent research.

Key Topics Covered:

Progression timelines
Response rates in therapy
Patient demographics and cytogenetics

9 Questions2 MinutesCreated by AnalyzingData342

Patients who progress within ______________ after initial therapy are considered a functional high-risk group.

60-90 days

6-12 months

12-18 months

1-2 years

The early relapse subgroup defined within the Poster analysis were patients with 1 prior line of therapy who relapsed....

<12 months after initiating 1L therapy

>18 months after initiating 1L therapy

<18 months after initiating 1L therapy

After receiving lenalidomide-based 1L therapy

MPFS for DVd vs Vd in the early relapse sub-group was...?

12.6 vs 6.2

15.4 vs 9.0

27.7 vs 7.9

36.9 vs 11.7

The mPFS for DVd vs Vd was 15.4 vs 9.0 in the early relapse sub-group with a HR of 0.51. What is the RRR?

49%

51%

15.4%

9.0%

What percentage of patients in the Vd arm of the early relapse sub-group achieved MRD-negativity?

13.3%

3.2%

Not reported

What percentage of patients in the DVd arm of the early relapse sub-group also had high-risk cytogenetics?

Not reported

14.5%

17.6%

26.3%

Comparing the response of early relapse patients that received DVd vs Vd, what level of response was considered statistically significant?

VGPR

None were statistically significant

Functional High-Risk

Functional High-Risk Quiz

More Quizzes